1 Min Read
May 15 (Reuters) - Alembic Pharmaceuticals Ltd
* Says received U.S. Food & drug administration (FDA) approval for fenofibric acid delayed-release capsules Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.